MedPath

Proof of Concept of Pediatric and Adolescent EXPLORER V2 Exoskeleton in Children With Neurological and Neuromuscular Disease

Not Applicable
Completed
Conditions
Neuromuscular Diseases in Children
Cerebral Palsy
Acquired Brain Injury
Interventions
Device: EXPLORER V2
Registration Number
NCT05914818
Lead Sponsor
MarsiBionics
Brief Summary

The goal of this clinical trial is to analyze the usability and safety of the prototype gait exoskeleton EXPLORE V2 in children with neurological and neuromuscular disease.

Participants will use the exoskeletons in their home and the community and variables regarding safety and usability will be measured and recorded.

Detailed Description

Neurological and neuromuscular diseases are the main cause of motor disability in children, leading to the inability to stand and walk in many cases. Exoskeletons are a useful tool in the rehabilitation of these children, but most of them are designed to be used in the clinical setting. EXPLORER V2 is a prototype of a robotic gait exoskeleton designed to assist gait in children with motor disability in their homes and the community. The aim of this study is to analyze the safety and usability of the EXPLORER V2 as a proof of concept.

A test phase will be conducted in healthy volunteers (phase 0) as a proof of concept with the aim of evaluating safety and usability in healthy participants prior to the use of the device in children with neurological and neuromuscular disease (phases 1 and 2). After this, participants will use the exoskeleton in 4 different ocassions, 1 in a laboratory of gait analysis and 3 in their homes and the community.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Medical authorization for standing, gait training and weight bearing.
  • Informed consent signed by legal guardians.
  • Maximum user weight of 35 kg.
  • Hip width (between greater trochanteres) ≤40 cm.
  • Length of the thigh (distance from the greater trochanter to the lateral condyle of the tibia) from 21cm to 36cm.
  • Tibia leg length (distance from the lateral condyle of the tibia to the lateral malleolus) from 20cm to 35cm.
  • Shoe size ≤38 (EU)
Exclusion Criteria
  • Spasticity equal to 4 on the Modified Ashworth Scale at the time of use of the device.
  • More than 20º of hip and/or knee flessum at the time of using the exoskeleton.
  • Necessity to walk with 15 of hip abduction.
  • Skin lesion on parts of the lower extremities that are in contact with the device.
  • Scheduled surgery scheduled during the study period.
  • History of fracture without trauma. History of bone fracture traumatic in lower extremities or pelvic girdle in the last 3 months.
  • Presence of other conditions causing exercise intolerance (such as uncontrolled hypertension, coronary artery disease, arrhythmia, congestive heart failure, severe pulmonary disease).
  • Conductual disorders that may interfere with the use of the device or their participation in the study, like impulsiveness or the inability to understand simple comands.
  • Allergy to any of the EXPLORER materials: cotton, nylon, polyester, PPS, PEEK or ABS.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
EXPLORER V2EXPLORER V21 session with the exoskeleton EXPLORER V2 in healthy subjects 3 sessions with the exoskeleton EXPLORER V2 in subjects with disease
Primary Outcome Measures
NameTimeMethod
Falls prevalencethrough study completion, along 6 weeks

Number of falling events ocurred from the participant or caregiver

Skin integritythrough study completion, along 6 weeks

Ocurrence of any injury of the skin in the areas of contact and produced by the use of the exoskeleton

Blood pressurethrough study completion, along 6 weeks

measurement of blood pressure when medical prescription

Oxygen saturationthrough study completion, along 6 weeks

measurement of Oxygen saturation when medical prescription

Interventions of the investigatorsthrough study completion, along 6 weeks

The amount of times that the investigators have to intervene in the session in order to avoid damage when the device is being used by the caregiver

Pain (Visual Analogic Scale)through study completion, along 6 weeks

pain measured by the Visual Analogic Scale (VAS) by the participant and the caregiver

Spasticitythrough study completion, along 6 weeks

spasticity measured by the Modified Ashworth Scale (MAS)

Kinematic data during gaitOnce, during the first session with the exoskeleton

Kinematic values for each joint of the lower limb during gait, assessed by photogrammetry in a gait analysis laboratory both in healthy subjects and participants with disease

Heart ratethrough study completion, along 6 weeks

measurement of heart rate when medical prescription

Serious Adverse Eventsthrough study completion, along 6 weeks

occurrence of any serious adverse event to the participant or the caregiver

Participant satisfactionat the end of the intervention, 6th week

Satisfaction of the participant (caregiver) with the devicem measured by the Quebec User Evaluation of Satisfaction with Assistive Technology 2.0.

Number of stepsthrough study completion, along 6 weeks

Number of steps taken with the exoskeleton provided by the device

Walking timethrough study completion, along 6 weeks

Walking time while using the exoskeleton provided by the device

Donning and doffing timethrough study completion, along 6 weeks

Time to don and doff the device to each participant

Secondary Outcome Measures
NameTimeMethod
Accesssibility of the housethrough study completion, along 6 weeks

Rate of the houses suitable to use the device

Accesssibility of the participantthrough study completion, along 6 weeks

Rate of the participants suitable to use the device

Accesssibility of the exterior spacesthrough study completion, along 6 weeks

Rate of the exterior spaces that are suitable to use the device

AcceptabilityAt the end of the study, 6th week

Analysis of the drop-out rate during the study period

Trial Locations

Locations (5)

Hospital Universitario Gregorio Marañón

🇪🇸

Madrid, Spain

Hospital Infantil Universitario Niño Jesús-Servicio de Rehabilitación

🇪🇸

Madrid, Spain

Hospital Universitario Niño Jesús-Servicio de Neuro Ortopedia

🇪🇸

Madrid, Spain

Hospital Universitario 12 de Octubre

🇪🇸

Madrid, Spain

Hospital Universitario La Paz

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath